Search - Prime Therapeutics
Navigate to
-
publications Pancreatic cancer: Innovative therapy approved, but unmet need continues April 14, 2025 Author: Simone Ndujiuba, PharmD, BCOP In the United States, pancreatic cancer is the fourth...
-
Cover image for Prime Therapeutics prioritizes patient-centered care, stays ahead of oncology trends Prime simplifies the cancer care pathway through innovative solutions that help manage complex...
PA Sub-Categories: Specialty drugs Products Prime Article: Stories -
Pat Gleason, assistant vice president, health outcomes, and David Eckwright, senior director, clinical project and program management, share an overview of Prime’s data and insights slated for this...
PA Sub-Categories: GLP-1 Technology Specialty drugs Products Prime Article: Perspectives -
Breadcrumb Home Newsroom Custom Content Prime Careers Spotlight Prime Careers Spotlight: October 2025 Prime Careers Spotlight: October 2025 Check out our latest job openings. Together, we can help...
-
Eyebrow High-Cost Therapy Profile: February Detailed information about Marnetegragene autotemcel Intravenous (IV) High Cost Therapy Profile Gene Therapy/Immunology Marnetegragene autotemcel...
-
publications Optimizing immunoglobulin use in multiple myeloma: clinical and managed care perspectives September 19, 2025 Author: Abby Kim, PharmD, BCOP Multiple myeloma (MM) is a hematologic...
-
Prime works to simplify medication management and support patients with migraine, making migraine treatment less of a pain point
Prime Article: Stories -
publications BiTEs and roadblocks June 25, 2025 Author: Simone Ndujiuba, PharmD, BCOP US Food and Drug Administration (FDA) has approved fourteen bispecific antibody drugs to treat a variety of...